SuperworthAnixa Biosciences shares outstanding ANIX
Diluted shares outstanding, averaged over each quarter, from 2011.
- Latest quarter, to Jul 31, 2026
- 34.2M
- On a year earlier
- +5.3%
- more shares
Anixa Biosciences had 34.2M diluted shares outstanding on average in Q3 FY26, the quarter to Jul 31, 2026.
That is 5.3% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 32.9M | +2% |
| FY2024 | 32.2M | +3% |
| FY2023 | 31.1M | +1% |
| FY2022 | 30.8M | +2% |
| FY2021 | 30M | +26% |
| FY2020 | 23.9M | +18% |
| FY2019 | 20.2M | +8% |
| FY2018 | 18.7M | +20% |
| FY2017 | 15.7M | +79% |
| FY2016 | 8.7M | +0% |
| FY2015 | 8.7M | −3% |
| FY2014 | 9M | +8% |
| FY2013 | 8.3M | +12% |
| FY2012 | 7.4M | +6% |
| FY2011 | 7M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q3 FY26 | 34.2M | +5% | |
| Q2 FY26 | 33.6M | +4% | |
| Q1 FY26 | 33.2M | +3% | |
| Q4 FY25 | 32.9M | +2% | |
| Q3 FY25 | 32.5M | +1% | |
| Q2 FY25 | 32.2M | +1% | |
| Q1 FY25 | 32.2M | +2% | |
| Q4 FY24 | 32.2M | +3% | |
| Q3 FY24 | 32.1M | +3% | |
| Q2 FY24 | 31.9M | +3% | |
| Q1 FY24 | 31.4M | +2% | |
| Q4 FY23 | 31.1M | +1% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Anixa Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.